You are here

ASCO GU

ASCO GU: Pfizer touts Talzenna's strong showing in PARP prostate cancer battle with AstraZeneca, J&J

Fierce Pharma

Fri, 02/17/23 - 09:36 am

prostate cancer

Merck's Keytruda Plus Eisai's Lenvima Could Open New Standard of Care in Renal Cancer

BioSpace

Tue, 02/16/21 - 11:12 am

renal cell carcinoma

ASCO GU: Bristol Myers touts first-in-class Opdivo win in muscle-invasive bladder cancer

Fierce Pharma

Tue, 02/9/21 - 01:02 pm

Bristol-Myers Squibb

muscle-invasive urothelial carcinoma